102 related articles for article (PubMed ID: 38610018)
21. Ablation of ERO1A induces lethal endoplasmic reticulum stress responses and immunogenic cell death to activate anti-tumor immunity.
Liu L; Li S; Qu Y; Bai H; Pan X; Wang J; Wang Z; Duan J; Zhong J; Wan R; Fei K; Xu J; Yuan L; Wang C; Xue P; Zhang X; Ma Z; Wang J
Cell Rep Med; 2023 Oct; 4(10):101206. PubMed ID: 37769655
[TBL] [Abstract][Full Text] [Related]
22. The molecular basis of nutrient sensing and signalling by mTORC1 in metabolism regulation and disease.
Goul C; Peruzzo R; Zoncu R
Nat Rev Mol Cell Biol; 2023 Dec; 24(12):857-875. PubMed ID: 37612414
[TBL] [Abstract][Full Text] [Related]
23. PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.
Glaviano A; Foo ASC; Lam HY; Yap KCH; Jacot W; Jones RH; Eng H; Nair MG; Makvandi P; Geoerger B; Kulke MH; Baird RD; Prabhu JS; Carbone D; Pecoraro C; Teh DBL; Sethi G; Cavalieri V; Lin KH; Javidi-Sharifi NR; Toska E; Davids MS; Brown JR; Diana P; Stebbing J; Fruman DA; Kumar AP
Mol Cancer; 2023 Aug; 22(1):138. PubMed ID: 37596643
[TBL] [Abstract][Full Text] [Related]
24. Jing-Fang n-butanol extract and its isolated JFNE-C inhibit ferroptosis and inflammation in LPS induced RAW264.7 macrophages via STAT3/p53/SLC7A11 signaling pathway.
Li X; Qi H; Zhang X; Liang H; Zeng N
J Ethnopharmacol; 2023 Nov; 316():116689. PubMed ID: 37315642
[TBL] [Abstract][Full Text] [Related]
25. Zooming in and out of ferroptosis in human disease.
Wang X; Zhou Y; Min J; Wang F
Front Med; 2023 Apr; 17(2):173-206. PubMed ID: 37121959
[TBL] [Abstract][Full Text] [Related]
26. Ferroptosis: A flexible constellation of related biochemical mechanisms.
Dixon SJ; Pratt DA
Mol Cell; 2023 Apr; 83(7):1030-1042. PubMed ID: 36977413
[TBL] [Abstract][Full Text] [Related]
27. Lipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis.
Rochette L; Dogon G; Rigal E; Zeller M; Cottin Y; Vergely C
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613888
[TBL] [Abstract][Full Text] [Related]
28. Overcoming cancer chemotherapy resistance by the induction of ferroptosis.
Wang Y; Wu X; Ren Z; Li Y; Zou W; Chen J; Wang H
Drug Resist Updat; 2023 Jan; 66():100916. PubMed ID: 36610291
[TBL] [Abstract][Full Text] [Related]
29. Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis.
Li Y; Yang W; Zheng Y; Dai W; Ji J; Wu L; Cheng Z; Zhang J; Li J; Xu X; Wu J; Yang M; Feng J; Guo C
J Exp Clin Cancer Res; 2023 Jan; 42(1):6. PubMed ID: 36604718
[TBL] [Abstract][Full Text] [Related]
30. The role of IL-6/JAK2/STAT3 signaling pathway in cancers.
Huang B; Lang X; Li X
Front Oncol; 2022; 12():1023177. PubMed ID: 36591515
[TBL] [Abstract][Full Text] [Related]
31. The endoplasmic reticulum kinase PERK interacts with the oxidoreductase ERO1 to metabolically adapt mitochondria.
Bassot A; Chen J; Takahashi-Yamashiro K; Yap MC; Gibhardt CS; Le GNT; Hario S; Nasu Y; Moore J; Gutiérrez T; Mina L; Mast H; Moses A; Bhat R; Ballanyi K; Lemieux H; Sitia R; Zito E; Bogeski I; Campbell RE; Simmen T
Cell Rep; 2023 Jan; 42(1):111899. PubMed ID: 36586409
[TBL] [Abstract][Full Text] [Related]
32. Recent progress in ferroptosis: inducers and inhibitors.
Du Y; Guo Z
Cell Death Discov; 2022 Dec; 8(1):501. PubMed ID: 36581640
[TBL] [Abstract][Full Text] [Related]
33. Elevated ITGA5 facilitates hyperactivated mTORC1-mediated progression of laryngeal squamous cell carcinoma via upregulation of EFNB2.
Li D; Sun A; Zhang L; Ding Z; Yi F; Yang X; Wang Z; Chen X; Liu W; Liu S; Shen H; Miao M; Zhang L; Liu P; Liu Y; Su S; Huang H; Huang C; Hu Z; Zhang H; Zha X; Liu Y
Theranostics; 2022; 12(17):7431-7449. PubMed ID: 36438491
[No Abstract] [Full Text] [Related]
34. STAT3/miR-130b-3p/MBNL1 feedback loop regulated by mTORC1 signaling promotes angiogenesis and tumor growth.
Li H; Liu P; Li D; Wang Z; Ding Z; Zhou M; Chen X; Miao M; Ding J; Lin W; Liu Y; Zha X
J Exp Clin Cancer Res; 2022 Oct; 41(1):297. PubMed ID: 36217202
[TBL] [Abstract][Full Text] [Related]
35. Recent advances and limitations of mTOR inhibitors in the treatment of cancer.
Ali ES; Mitra K; Akter S; Ramproshad S; Mondal B; Khan IN; Islam MT; Sharifi-Rad J; Calina D; Cho WC
Cancer Cell Int; 2022 Sep; 22(1):284. PubMed ID: 36109789
[TBL] [Abstract][Full Text] [Related]
36. ERO1 alpha deficiency impairs angiogenesis by increasing N-glycosylation of a proangiogenic VEGFA.
Varone E; Chernorudskiy A; Cherubini A; Cattaneo A; Bachi A; Fumagalli S; Erol G; Gobbi M; Lenardo MJ; Borgese N; Zito E
Redox Biol; 2022 Oct; 56():102455. PubMed ID: 36063727
[TBL] [Abstract][Full Text] [Related]
37. Overview of Research into mTOR Inhibitors.
Mao B; Zhang Q; Ma L; Zhao DS; Zhao P; Yan P
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014530
[TBL] [Abstract][Full Text] [Related]
38. LncRNA HEPFAL accelerates ferroptosis in hepatocellular carcinoma by regulating SLC7A11 ubiquitination.
Zhang B; Bao W; Zhang S; Chen B; Zhou X; Zhao J; Shi Z; Zhang T; Chen Z; Wang L; Zheng X; Chen G; Wang Y
Cell Death Dis; 2022 Aug; 13(8):734. PubMed ID: 36008384
[TBL] [Abstract][Full Text] [Related]
39. SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma.
Chen Q; Zheng W; Guan J; Liu H; Dan Y; Zhu L; Song Y; Zhou Y; Zhao X; Zhang Y; Bai Y; Pan Y; Zhang J; Shao C
Cell Death Differ; 2023 Jan; 30(1):137-151. PubMed ID: 35995846
[TBL] [Abstract][Full Text] [Related]
40. Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications.
Stockwell BR
Cell; 2022 Jul; 185(14):2401-2421. PubMed ID: 35803244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
